Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NCT06532279 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
98
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

NRG Oncology